Several post-doctoral positions for immediate recruitment in the area of Nanomedicine, Immunotherapy, Cancer Gene Therapy, and Exosomes for Lung Cancer is available at the NCI-Designated Stephenson Cancer Center, University of Oklahoma Health Sciences Center (OUHSC) in Oklahoma City, Oklahoma. For all of the positions, highly motivated individuals with PhD., MD., or MD/PhD degree with good communication and writing skills in English are encouraged to apply.
First position is open to study the host-immune-response towards a RNA-binding protein in cancer. Candidate for this position should have strong experience in cancer immunology especially in the area of T- and NK cell biology. Knowledge of CAR-T cells is a plus. Studies will involve in vitro and in vivo studies and prior knowledge and expertise in the use of appropriate techniques and animal models is essential. Publications in relevant areas in peer-reviewed journals is required.
Second position is open to study the biogenesis and role of cancer exosomes in resistance to chemotherapy and immunotherapy. Candidates with prior experience in exosome and extracellular vesicle (EV) biology, biogenesis, and/or therapy is essential. Study will focus on investigating how exosomes and EVs negate cancer therapeutics and contribute to therapy failure. Studies will involve pre-clinical and clinical studies and handling of cancer patient samples (blood, urine, tissues, etc.) is expected. Publications in relevant areas in peer-reviewed journals is required.
Third position is open in the area of cancer nanomedicine and drug delivery. Individuals with expertise in synthesis of nanoparticles (lipid, polymer-, metal-based) for tumor-targeted drug (chemotherapy, plasmid DNA, siRNA, miRNA, imaging agents, etc.) delivery are eligible to apply. Experience in animal models (xenograft, PDX), nanoparticle synthesis, identifying new tumor targets for drug delivery, etc. is essential. Publications in relevant areas in peer-reviewed journals is required.
Fourth position is open to study interleukin (IL)-24 in cancer and immunity. Individuals with expertise in molecular biology, gene cloning, CRISPR/Cas 9, apoptosis, western blotting, animal tumor models, flow-cytometry, organoids, etc., is essential. Publications in relevant area of research in peer-reviewed journals is required.
To apply, please email a cover letter stating your research interests and experience along with curriculum vitae and three references to:
Dr. Rajagopal Ramesh
Professor & Jim and Christy Everest Endowed Chair in Cancer Developmental Therapeutics
Department of Pathology,
University of Oklahoma Health Sciences Center
975 N.E., 10th Street
Oklahoma City, OK 73104
Phone: (405) 271-6101
The Stephenson Cancer Center is an NCI-designated cancer center with interacting teams of scientists supported by an array of core facilities and located on a large OUHSC research campus. OUHSC is one of only four comprehensive academic health centers in the nation with seven health professional schools, providing a broad base of expertise for comprehensive clinical and basic science research, interdisciplinary interaction, and career development. Oklahoma City is a large metropolis with western charm, easy local transportation, vibrant downtown, and excellent suburbs.
The University of Oklahoma is an EO/AA Institution http://www.ou.edu/eoo/. Individuals with disabilities and protected veterans are encouraged to apply